Skip to content

Clinical Study of Xiaobai Recipe Granules on Treatment of proteinuria in the patients with Chronic Glomerulonephritis (CKD1-2 stage)

Clinical Study of Xiaobai Recipe Granules on Treatment of proteinuria in the patients with Chronic Glomerulonephritis (CKD1-2 stage)

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003397
Enrollment
Unknown
Registered
2020-06-08
Start date
2020-06-06
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Glomerulonephritis CKD1-2

Interventions

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. 160 patients with primary chronic glomerulonephritis had typical clinical symptoms of chronic nephritis, which met the western medicine diagnostic criteria of chronic nephritis. 2. The syndrome differentiation of traditional Chinese medicine belongs to the type of "deficiency of spleen and kidney qi, and dampness heat and stasis"; 3. Patients with chronic kidney disease (CKD) stage 1-2, GFR >= 60ml / min / 1.73m2; 4. Patients aged 18-65; 5. Effective control of hypertension (blood pressure 130-100 / 80-60mmhg); 6. Patients whose blood potassium is within the normal range; 7. 2.5g/24h >= 24h urinary protein >= 0.5g/24h; 8. Patients who sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed as acute nephritis after infection or patients with renal damage due to essential hypertension; 2. In the past three months, western medicine glucocorticoid, immunosuppressant and Tripterygium wilfordii have been used in patients with chronic nephritis; 3. Pregnant or preparing pregnant and lactating women; 4. Patients with chronic nephritis not caused by primary kidney disease; 5. Patients who are known to be allergic to such drugs, patients with psychosis, and patients who cannot cooperate; 6. Patients who are participating in clinical trials of other drugs or who have participated in other clinical trials within 3 months.

Design outcomes

Primary

MeasureTime frame
Tongue image;Pulse condition;physical examination;TCM syndrome integral;

Countries

China

Contacts

Public ContactChen Wang

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

chenwang42@163.com+86 13641836499

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026